White-matter changes on MRI as surrogate marker

Area of Science:

• Neurology
• Radiology
• Clinical Trials

Background:

• Vascular dementia is a significant cause of cognitive decline.
• Magnetic Resonance Imaging (MRI) is frequently used in neurological research.
• White-matter changes are common findings on MRI in elderly populations.

Purpose of the Study:

• To review the utility of white-matter changes on MRI as a surrogate marker in clinical trials for vascular dementia.
• To assess the current evidence supporting the use of white-matter changes in clinical trial design.

Main Methods:

• Literature review of studies using MRI to assess white-matter changes in vascular dementia.
• Analysis of the sensitivity to change and measurement error of current assessment methods for white-matter changes.
• Evaluation of the suitability of white-matter changes as a surrogate endpoint in clinical trials.

Main Results:

• Insufficient evidence currently supports the use of white-matter changes as a surrogate marker in vascular dementia trials.
• Existing methods for rating or volumetric assessment of white-matter changes show limited sensitivity to change.
• High measurement error associated with current methods further restricts their reliability.

Conclusions:

• White-matter changes on MRI are not yet validated as reliable surrogate markers for vascular dementia clinical trials.
• Further research is needed to improve the sensitivity and reduce the measurement error of MRI-based assessments.
• Current limitations preclude the implementation of white-matter changes as a standard surrogate marker in these trials.